Table 4.
Disproportionality analysis results for reported proton pump inhibitor-associated subacute cutaneous lupus erythematosus
| Sex | Measure | Ratio (95 % CI) |
|---|---|---|
| All | Proportional reporting ratio | 36.64 (28.10–47.77) |
| Relative odds ratio | 36.72 (28.16–47.89) | |
| Relative reporting ratio | 17.20 (13.77–21.48) | |
| Female | Proportional reporting ratio | 40.59 (29.97–54.99) |
| Relative odds ratio | 40.71 (30.05–55.17) | |
| Relative reporting ratio | 18.00 (14.03–23.09) | |
| Male | Proportional reporting ratio | 13.85 (6.18–31.07) |
| Relative odds ratio | 13.86 (6.18–31.09) | |
| Relative reporting ratio | 9.40 (4.41–20.07) |
CI confidence interval